Latest: FDA Approves New Biosimilar for Oncology Treatment
Digital Health

Cascala Health Secures $8.6M for AI-Enabled Clinical Intelligence Platform for Post-Acute Care

by HIT Consultant
0 Comments
0 Mins
What You Should Know: – Cascala Health, a healthcare technology company based in Boston secures $8.6M in seed financing co-led by Flare Capital Partners and Eniac Ventures, with additional backing from Omega Healthcare Investors, Ziegler Link-age Fund, Tau Ventures, and Digital Health Venture Partners. This brings the company’s total funding to $11.23M since its launch ... Read More
Tags:
HIT Consultant
Author

HIT Consultant

Previous Post
Magnesium Depletion Linked to Depression, and How to Replenish It Effectively
Next Post
Refining Treatment Timelines and Immunotherapy Strategies in Early-Stage NSCLC: Jonathan Thompson, MD, MS
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago